5.40
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
Is Neuphoria Therapeutics Inc. stock attractive after correctionWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Published on: 2025-10-27 05:30:38 - newser.com
Can Neuphoria Therapeutics Inc. stock maintain operating marginsJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com
Neuphoria Therapeutics Inc.’s volatility index tracking explainedPortfolio Performance Report & Consistent Return Investment Signals - newser.com
Automated trading signals detected on Neuphoria Therapeutics Inc.Market Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Why hedge funds are buying Neuphoria Therapeutics Inc. stockJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
Using AI based signals to follow Neuphoria Therapeutics Inc.2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Why analysts upgrade Neuphoria Therapeutics Inc. stockWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Will Neuphoria Therapeutics Inc. stock keep outperforming rivalsPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
Can Neuphoria Therapeutics Inc. stock hit analyst price targets2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
How Neuphoria Therapeutics Inc. stock performs in interest rate cyclesTrade Entry Summary & Weekly High Momentum Picks - newser.com
Best Biotech Stocks To Keep An Eye OnOctober 25th - MarketBeat
Published on: 2025-10-26 11:08:10 - newser.com
Published on: 2025-10-26 10:45:26 - newser.com
Neuphoria Therapeutics Advances BNC-210 Trial with Prolonged Cash Runway - StocksToTrade
Neuphoria Therapeutics Phase 3 Trial Progress Spurs Investor Optimism - timothysykes.com
Published on: 2025-10-26 11:32:54 - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):